2020 Schedule

Thursday, Sept. 10

Basic Science Pathway

8:45 a.m. – 9:10 a.m.
Welcome Remarks
Mitchell S. V. Elkind, MD, MS, FAAN, AHA President, New York, NY
Karen Griffin, MD, FAHA, Hines, IL


9:10 a.m. – 10:00 a.m. Keynote Lecture: Genetics of Primary Aldosteronism
Ute Scholl, MD, Berlin, Germany

10:00 a.m. – 11:00 a.m.
Recent Advances Session 1: Results from SPRINT Sub-studies
Moderator: Suzanne Oparil, MD, FAHA, Birmingham, AL

10:00 a.m. SPRINT HEART FAILURE
Bharathi Upadhya, MD, Winston-Salem, NC

10:20 a.m. What is Good for the Heart is Good for the Brain: SPRINT MIND Results
Mark Supiano, MD, Salt Lake City, UT

10:40 a.m. SPRINT KIDNEY
Tara Chang, MD, MS, Palo Alto, CA

11:00 a.m. – 12:30 p.m.
Recent Advances Session 2: Debate: Should we lower nighttime BP with bedtime dosing of antihypertensive medications?
Moderator: Jordana Cohen, MD, MSCE, Philadelphia, PA

11:00 a.m. Presentation of a Clinical Case (Ground Rounds) and Lecture: Nighttime BP and Chronotherapy in Hypertension and CVD
Marwah Abdalla, MD, MPH, FAHA, New York, NY

DEBATE:
11:30 a.m. Pro: Dose at Bedtime
Ramon C. Hermida, PhD, FAHS, FAHA, Vigo, Spain

11:45 a.m. 
Con: Dose During the Day
Swapnil Hiremath, MD, MPH, Ottawa, ON
 
12:00 p.m.
Response 1
12:05 p.m. Response 2

12:10 p.m. – 12:30 p.m.
Discussion / Q&A

CPCS & Primary Care Pathway

8:45 a.m. – 9:10 a.m.
Welcome Remarks
Mitchell S. V. Elkind, MD, MS, FAAN, AHA President, New York, NY
Karen Griffin, MD, FAHA, Hines, IL


9:10 a.m. – 10:00 a.m. Keynote Lecture: Genetics of Primary Aldosteronism
Ute Scholl, MD, Berlin, Germany

10:00 a.m. – 11:30 a.m.
Clinical Practice/Clinical Science
C01: Angiotensin Degrading Enzymes and Their Therapeutic Potential
Moderator: Daniel Batile, MD, FAHA, Chicago, IL

10:00 a.m. Novel Short ACE2 Variants
Jan A. Wysocki, MD, PhD, Chicago, IL

10:30 a.m. Neprilysin Inhibitors
Mark C. Chappell, PhD, FAHA, Winston-Salem, NC

11:00 a.m. Aminopeptidase A Inhibition
Catherine Llorens-Cortes, PhD, Paris, France

11:30 a.m. - 12:20 p.m.
Clinical Practice/Clinical Science
C02. What Level of Evidence is Needed to Change Clinical Practice? Chlorthalidone vs. HCTZ
Moderator: Tara Chang, MD, MS, Palo Alto, CA

11:30 a.m. Overview of Historical Data and Pharmacologic Differences Between Chlorthalidone and HCTZ
James M. Luther, MD, FAHA, Nashville, TN

11:40 a.m. Randomized Controlled Trial Evidence
William C. Cushman, MD, FAHA, Memphis, TN

12:00 p.m. Big Data Evidence
Paul Muntner, PhD, FAHA, Birmingham, AL

12:20 p.m. - 1:20 p.m.
Clinical Practice/Clinical Science
C03. Emerging Tools and Analytica Approaches in Hypertension in 2020
Moderator: Paul Drawz, MD, Minneapolis, MD 

12:20 p.m. AI/Machine Learning in Blood Pressure Management
Chayakrit Kirttanawong, MD, Houston, TX

12:40 p.m. Cuffless Blood Pressure Measurement
Tammy McLoughlin, MD, PhD, Baltimore, MD

1:00 p.m. Approaches to Out-of-Office Blood Pressure Monitoring in Pediatric Patients
Elaine M. Urbina, MD, MS, FAHA, Cincinnati, OH

Friday, Sept. 11

Basic Science Pathway

9:00 a.m. – 10:00 a.m.
Recent Advances Session 3: A Focus on Women's Health
Moderator: Styliani Goulopoulou, PhD, FAHA, Fort Worth, TX

9:00 a.m. Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy
Sarosh Rana, MD, MPH, Chicago, IL

9:30 a.m. Estrogen Receptor Signaling in Vascular Remodeling and Stiffness
Sarah H Lindsey, PhD, FAHA, New Orleans, LA

10:00 a.m. – 11:00 a.m.
Recent Advances Session 4: Links Between the Renin-angiotensin System and SARs-CoV-2 and COVID-19
Moderator: Matthew A Sparks, MD, FAHA, Durham, NC

10:00 a.m. ACE2 From Renoprotection to a Potential Therapy for Coronavirus Infection
Daniel Batlle, MD, FAHA, Chicago, IL

10:30 a.m. RAS Inhibitors in Hypertension and Heart Failure: Truths and Mistruths of Treatment in the COVID-19 Era
Jordana Cohen, MD, MSCE, Philadelphia, PA

11:00 a.m. – 12:00 p.m.
Excellence Award Lecture and presentation of the The Marvin Moser Clinical Hypertension Award and the Irvine Page & Alva Bradley Lifetime Achievement Award

11:00 a.m. Introduction of the Excellence Award Lecture

11:05 a.m. Excellence Award Lecture: White Coat Hypertension: Pathophysiological and Clinical Aspects
Giuseppe Mancia, MD, PhD, Milan, Italy

11:35 a.m. The Marvin Moser Clinical Hypertension Award
Jackson T. Wright, MD, PhD, FAHA, Cleveland, OH

11:45 a.m. The Irvine Page & Alva Bradley Lifetime Achievement Award
Anil Bidani, MD, FAHA, Hines, IL

12:00 p.m. – 1:30 p.m.
Clinical Pathways Session sponsored by Hypertension (Zoom session)


Case 1: CONNed in Pregnancy
Dr. Spoorthy Kulkarni, MD, MRCP, Cambridge, UK
Prof. Ian Wilkinson, DM FRCP, Cambridge, UK

Case 2: Renovascular Hypertension: One Size Does Not Fit All - Challenges in Diagnosis and Management
Abhilash Koratala MD FASN, Milwaukee, Wisconsin
Rajesh Mohandas MD FAHA, University of Florida, Gainesville, Florida

CPCS & Primary Care Pathway

9:00 a.m. – 10:15 a.m.
Primary Care - C04. Strategies for Getting Your Practice to Goal
Moderator: Jeffrey Brettler, MD, Los Angeles, CA

9:00 a.m. Initiating and Intensifying Treatment: Do Treatment Algorithms Work?
Romsai Tony Boonyasai, MD, MPH, Baltimore, MD

9:15 a.m. Team-Based Approaches That Work
Eric J. MacLaughlin, PharmD, FASHP, FCCP, BCPS, Amarillo, TX

9:30 a.m. Community-Based Approaches: Barbershops
Keith Ferdinand, MD, FAHA, New Orleans, LA

9:45 a.m. Practice Facilitation to Get to Goal in a Primary Care Network
Shari D. Bolen, MD, MPH, Cleveland, OH

10:15 a.m. – 10:45 p.m.
Primary Care
C05. Hypertension Quality Metrics that Matter


10:15 a.m. Hypertension Quality Metrics that Matter
Valy Fontil, MD, MAS, MPH, San Francisco, CA

11:00 a.m. - 12:00 p.m.
Excellence Award Lecture and presentation of the The Marvin Moser Clinical Hypertension Award and the Irvine Page & Alva Bradley Lifetime Achievement Award


11:00 a.m. Introduction of the Excellence Award Lecture

11:05 a.m. Excellence Award Lecture: White Coat Hypertension: Pathophysiological and Clinical Aspects
Giuseppe Mancia, MD, PhD, Milan, Italy

11:35 a.m. The Marvin Moser Clinical Hypertension Award
Jackson T. Wright, MD, PhD, FAHA, Cleveland, OH

11:45 a.m. The Irvine Page & Alva Bradley Lifetime Achievement Award
Anil Bidani, MD, FAHA, Hines, IL

12:00 p.m. – 1:30 p.m.
Clinical Pathways Session sponsored by Hypertension (Zoom session)


Case 1
CONNed in Pregnancy
Dr. Spoorthy Kulkarni, MD, MRCP, Cambridge, UK
Prof. Ian Wilkinson, DM FRCP, Cambridge, UK

Case 2
Renovascular Hypertension: One Size Does Not Fit All - Challenges in Diagnosis and Management
Abhilash Koratala MD FASN, Milwaukee, Wisconsin
Rajesh Mohandas MD FAHA, University of Florida, Gainesville, Florida

Saturday, Sept. 12

Basic Science Pathway

8:50 a.m. – 11:00 a.m.
Awards Session

8:50 a.m. Introductions

9:00 a.m. Arthur C. Corcoran Memorial Lecture: From Brain to Blood Vessel - Insights from Muscle Sympathetic Nerve Recordings
John Floras, MD, Dphil, FAHA, Toronto, ON

9:20 a.m. Lewis K. Dahl Memorial Lecture: NO News is Good News
Jennifer S. Pollock, PhD, FAHA, FAPS, Birmingham, AL

9:40 a.m. Harriet Dustan Award Lecture: Chemerin - A Connection Between Obesity and Hypertension
Stephanie Watts, PhD, FAHA, East Lansing, MI

10:00 a.m. Donald Seldin Lecture: Regulation of Blood Pressure by Renal Intercalcated Cells
Susan M. Wall, MD, FAHA, Atlanta, GA

10:20 a.m. Mid-Career Award for Research Excellence: Heme Redox Cycling and Blood Pressure Control
Adam Straub, PhD, Pittsburgh, PA

10:40 a.m. Harry Goldblatt Award for Early Career Investigators: Role of Oxidative Protein Modifications in Salt-Induced Hypertension and Kidney Disease
Annet Kirabo, DVM, PhD, FAHA, Nashville, TN

11:00 a.m. – 12:20 p.m.
Recent Advances Session 5: KCVD Council Symposia: BP Genetics 2.0: Beyond Monogenetic Investigation
Moderator: Alicia A McDonough, PhD, FAHA, Los Angeles, CA

11:00 a.m. Genetic Determinants of Blood Pressure Determinants in Trans-Ethnic Association Studies
Adriana Hung, MD, MPH, Nashville, TN

11:20 a.m. Blood Pressure Genetic Risk Score Predicts Blood Pressure Responses to Dietary Sodium and Potassium
Tanika Kelly, PhD, MPH, New Orleans, LA

11:40 a.m. GSTM1 Gene, Diet, and Kidney Disease Progression
Thu H Le, MD, FAHA, Rochester, NY

12:20 p.m. – 1:20 p.m.
Oral Abstracts
AOS1. Preeclampsia, Pregnancy and Pediatric Hypertension
Moderator: Justin L Grobe, PhD, FAHA, Milwaukee, WI

12:20 p.m. Male Sprague Dawley Rats Exposed To Perinatal Hypoxia Are More Susceptible To Angiotensin II-induced Hypertension In Adulthood Vs Females
Lindsay A. Ramirez. Augusta University, Augusta, GA

12:30 p.m. Increased Complement Regulator CD55 Is Associated With A Reduction In Pancreatic Beta Cell Area In Islets Of Rat Offspring Following Chronic Placental Ischemia-induced Hypertension
Jean F Regal, University of Minnesota, Duluth, MN

12:40 p.m. Preeclampsia-induced T Helper-associated Cytokine Imbalances Persist Postpartum
Sabrina M Scroggins, University of Iowa, Iowa City, IA

12:50 p.m. Molecular Profile Of Peripheral Blood Mononuclear Cells In Hypertensive Adolescents With Target Organ Damage
Fnu Mohammed Arif, University of Cincinnati, Cincinnati, OH

1:00 p.m. White Coat Hypertension Stability In Children And Adolescents: Pediatric Nephrology Research Consortium Study
Yosuke Miyashita, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA

1:10 p.m. Comparison Between Ambulatory BP Percentile And Load As Predictors Of Target Organ Damage In Youth
Gilad Hamdani, Schneider Children's Medical Center, Petah Tikva, Israel

CPCS & Primary Care Pathway

8:50 a.m. – 11:00 a.m.
Awards Session

9:00 a.m.
Arthur C. Corcoran Memorial Lecture: From Brain to Blood Vessel: Insights from Muscle Sympathetic Nerve Recordings
John Floras, MD, Dphil, FAHA, Toronto, ON

9:20 a.m. Lewis K. Dahl Memorial Lecture: NO News is Good News
Jennifer S. Pollock, PhD, FAHA, FAPS, Birmingham, AL

9:40 a.m. Harriet Dustan Award Lecture: Chemerin: A Connection Between Obesity and Hypertension 
Stephanie Watts, PhD, FAHA, East Lansing, MI

10:00 a.m. Donald Seldin Lecture: Regulation of Blood Pressure by Renal Intercalcated Cells
Susan M. Wall, MD, FAHA, Atlanta, GA

10:20 a.m. Mid-Career Award for Research Excellence: Heme Redox Cycling and Blood Pressure Control
Adam Straub, PhD, Pittsburgh, PA

10:40 a.m. Harry Goldblatt Award for Early Career Investigators: Role of Oxidative Protein Modifications in Salt-Induced Hypertension and Kidney Disease
Annet Kirabo, DVM, PhD, FAHA, Nashville, TN

11:00 a.m. – 12:45 p.m.
Primary Care
C07. Hypertension Management in the Era of Covid-19: Has the Time for Remote Patient Monitoring of Hypertension Finally Arrived?
Moderator: Richard McManus, PhD, Oxford, UK
 
11:00 a.m. Comparing Approaches to Remote Patient Monitoring of Hypertension
Steven A. Yarows, MD, FAHA, Chelsea, MI

11:30 a.m. New Billing Codes for SMBP and ABPM
J Brian B Byrd, MD, FAHA, Ann Arbor, MI

11:50 a.m. Implementation Challenges and Opportunities in Low Income and Minority Patient Populations
Gbenga Ogedegbe, MD, MPH, New York, NY

12:25 p.m. The Importance of Using Validated BP Devices
James Sharman, PhD, Hobart, Australia

12:45 p.m. – 1:30 p.m.
Primary Care
C08. Treating Hypertension in Patients with Co-Morbid Conditions — Case-Based Discussion
Moderator: Valy Fontil, MD, MAS, MPH, San Francisco, CA

12:45 p.m. Heart Failure and or A-fib
Angela L Brown, MD, FAHA, St. Louis, MO

1:00 p.m. Chronic Kidney Disease
Maya Rao, MD, New York, NY

1:15 p.m. COPD
Shannon W. Finks, Pharm.D., FCCP, BCPS, BCCP, AHSCP-CHC, Memphis, TN

Sunday, Sept. 13

Basic Science Pathway

9:00 a.m. – 10:00 a.m.
Early Career Stage Awards Session


9:00 a.m. High Blood Pressure Research Council of Australia Award: Sex differences in para- and peri-renal adipose inflammation in obesity
Maria Jelinic BBSc MSc PhD, Melbourne, Australia

9:15 a.m. New Investigator Awards for Japanese Fellows
Nobuyuki Tokunaga, MD, Kumamoto-shi, Japan

9:30 a.m. AFHRE Award for Patient-Oriented or Clinical Research in Hypertension: Telemedicine And The Barbershop Model Of Hypertension Care For Black Men
Ciantel A. Blyler, PharmD, Cedars-Sinai Medical Center, Los Angeles, CA

9:45 a.m. AFHRE Award for Support of Underrepresented Minorities: Formyl Peptide Receptor-1 Activation Is Crucial For The Cause Of Spontaneous Hypertension In Dahl Salt Sensitive Rats
Jonnelle M. Edwards, PhD, University of Toledo, Toledo, OH

10:00 a.m. – 11:00 a.m.
AOS2. Genetics & Genetic Models of Hypertension
Moderator: Curt Sigmund, PhD, FAHA, Milwaukee, WI

10:00 a.m. Activation Of Neuronal At1R Exacerbates Hypertension-induced Reduction In Neuronal Function.
Jiaxi Xu, Jiaotong University, Xi'an, China

10:10 a.m. Deletion Of The Alpha Subunit Of EnNaC And MTORC2 Inhibition Attenuate DOCA-salt-induced Endothelial Cell And Vascular Stiffness.
Michael A Hill, University of Missouri, Columbia, MO

10:20 a.m. Histone Deacetylases 1 And 2 Regulate Six2 Function To Maintain Nephron Progenitor Cells During Nephrogenesis
Hongbing Liu, Tulane University, New Orleans, LA

10:30 a.m. Mouse Recombinant Soluble PRR-induced Increase Of Blood Pressure Is Sex-dependant In High Fat-fed Mice
Audrey A Poupeau, University of Kentucky, Lexington, KY

10:40 a.m. Role Of Pro-saas Peptides In Salt Resistance
Ines Armando, George Washington University, Washington, DC

10:50 a.m. The Etiology Of Inverse Salt Sensitivity Of Blood Pressure: Mirna-485-5p Binds To The Dopamine Type 2 Receptor (d2R) Snp Rs6276 And Decreases D2R Expression
John J Gildea, University of Virginia, Charlottesville, VA

11:00 a.m.– 12:00 p.m.
Oral Abstract Sessions 3
AOS3. Neural, Renal & Vascular Mechanisms in Hypertension
Moderator: Alexander Staruschenko, PhD, FAHA, Milwaukee, WI

11:00 a.m. Cholic Acid Supplementation Attenuates Hypertension In Spontaneously Hypertensive Stroke Prone Rats
Bojun Zhang, Baylor College of Medicine, Manvel, TX

11:10 a.m. Glyburide Treatment Improves Aortic Arch Pulse Wave Velocity In A Murine Model Of Alzheimer’S Disease
Nildris Cruz Diaz, Wake Forest School of Medicine, Winston-Salem, NC

11:20 a.m. The Role Of Opioid Receptors In Podocytes In The Development Of Hypertension In Dahl Salt-sensitive Rats
Daria Golosova, Medical College of Wisconsin, Milwaukee, WI

11:30 a.m. Progressive Alterations Of Mitochondrial Bioenergetics In The Kidney During The Development Of Salt-induced Hypertension
Namrata Tomar, Medical College of Wisconsin, Milwaukee, WI

11:40 a.m. Early Life Stress Sensitizes The Angiotensin II-elicited Hypertensive Response
Baojian Xue, University of Iowa, Iowa City, IA

11:50 a.m. Orexin Knockout BPH/2J Hypertensive Mice Still Have Elevated Basal Blood Pressure But Lower Stress Reactivity
Kristy L Jackson, Baker Heart and Diabetes Institute, Melbourne, Australia

CPCS & Primary Care Pathway

9:00 a.m. – 10:00 a.m.
Clinical Practice/Clinical Science
C09. Controversies in Secondary Hypertension: Case-Based Discussions
Moderator: John D Bisoganano, PhD, FAHA, Rochester, NY

9:00 a.m. When Do You Evaluate Patients for Hyperaldosteronism?
J Brian B Byrd, MD, FAHA, Ann Arbor, MI

9:15 a.m. What Factors Should Guide Treatment in Patients with Hyperaldosteronism?
Anand Vaidya, MD, MMSc, Boston, MA

9:30 a.m. When do you Refer Patients for Stenting in Renovascular Hypertension?
Marcel Ruzicka, MD, PhD, FRCPC, Ottawa, ON

9:45 a.m. When do You Evaluate Children for Renovascular Hypertension?
Joseph T. Flynn, MD, MS, FAHA, Seattle, WA

10:00 a.m. – 11:30 a.m.
Clinical Practice/Clinical Science
C10. Difficult Situations in Hypertension Management
Moderator: Debbie L Cohen, MD, Philadelphia, PA

10:00 a.m. Severe Obesity
Michael E. Hall, MD, FAHA, Jackson, MS

10:15 a.m. Refractory Hypertension
Raven Voora, MD, Chapel Hill, NC

10:30 a.m. Baroreflex Failure
Italo Biaggioni, MD, FAHA, Nashville, TN

10:45 a.m. Allostatic Load and Hypertension
Phillip D Levy, MD, MPH, FAHA, Detroit, MI

11:00 a.m. Adolescents
Joshua A Samuels, MD, MPH, FAHA, Houston, TX

This talk will be available OnDemand™
Environmental Contributors to Hypertension
Timothy B Plante, MD, Colchester, VT

 

11:30 a.m. – 1:10 p.m.
Clinical Practice/Clinical Science
C11. Prescribing and Deprescribing Antihypertensives
Moderator: Angela L Brown, MD, FAHA, St. Louis, MO 
 
11:30 a.m. Intensifying Treatment in the Inpatient Setting
Timothy Anderson, MD, Boston, MA

11:50 a.m. Orthostatic Hypotension
Stephen P Juraschek, MD, PhD, Boston, MA

12:10 p.m. Sick Day Protocols
Laurie Tomlinson, MBBS, MSc, PhD, London, UK

12:30 p.m. Prescribing cascades
Lisa McCarthy, PharmD, MSC, Toronto, ON

12:50 p.m. Discordant Blood Pressures: Masked and White Coat Hypertension
D. Edmund Anstey, MD, MPH, New York, NY

About This Meeting

Hypertension 2020 Scientific Sessions, focusing on recent advances in basic and clinical research on hypertension, is considered the premier scientific meeting on the subject in the world. A collaborative effort between the Council on Hypertension and the Council on the Kidney in Cardiovascular Disease, the science submitted to this conference continues to bring us the most up to date developments on our understanding of: the causes of hypertension; its relationship to stroke, cardiac disease and kidney dysfunction; and the most effective means for detecting, evaluating and treating high blood pressure across diverse populations.

The planned agenda includes almost 30 sessions during 3½ days, with more than 500 presentations focused on recent advances in hypertension research including oral and poster presentations selected from abstracts submitted by clinical and basic researchers as well as the Primary Care and Clinical Practice Clinical Science Tracks for Clinicians.

Target Audience

The conference is designed to benefit research scientists, clinicians, and other healthcare professionals in the fields of hypertension research, cardiology, nephrology, endocrinology and related disciplines.

Learning Objectives

  1. Discuss changes to the AHA/ACC guidelines for the management of hypertension and their clinical implications.
  2. Describe opportunities to improve blood pressure measurement in the clinical setting to provide more accurate results.
  3. Identify immune and inflammatory mechanisms that contribute to the development of hypertension and hypertension-related end-organ damage and discuss the research and clinical implications.
  4. Educate participants about medical approaches for the management of comorbid obesity in patients with hypertension.
  5. Describe new and emerging strategies for treating resistant hypertension.
  6. Describe participants on the impact of value-based reimbursement on hypertension management and identify opportunities to improve its management.